dr. pegram discusses the use of neratinib in her2 breast cancer
Published 6 years ago • 183 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:22
dr. pegram on challenges facing the treatment of her2-positive breast cancer
-
9:35
neratinib in her2 breast cancer
-
2:18
use of neratinib in her2-positive breast cancer
-
1:13
dr. pegram discusses adjuvant pertuzumab in her2 breast cancer
-
1:12
dr. pegram on challenges in neoadjuvant treatment for her2-positive breast cancer
-
2:14
dr. pegram on sequencing therapies in her2-positive breast cancer
-
1:18
dr. pegram on developing agents for patients with her2 breast cancer and brain metastases
-
1:53
dr. pegram on pertuzumab combination for her2-positive breast cancer
-
8:33
pending fda approval of neratinib in her2 breast cancer
-
1:05
dr. pegram on pertuzumab plus trastuzumab and chemotherapy in breast cancer
-
4:09
her2 breast cancer: neratinib patient selection
-
2:30
dr. pegram on neoadjuvant treatments for her2-postive breast cancer
-
1:02
dr. esteva discusses neratinib updates in her2 breast cancer
-
1:14
dr. hamilton on how neratinib targets her2 breast cancer
-
1:12
dr. nye on neratinib-associated diarrhea in her2 breast cancer
-
1:14
dr. lin on cns-specific outcomes with neratinib in her2 breast cancer
-
1:07
dr. mitri on neratinib and pertuzumab in her2-amplified breast cancer
-
2:03
dr. pegram on promising novel agents in her2 metastatic breast cancer
-
0:52
dr. gradishar on the role of neratinib in the treatment of her2 breast cancer